Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

AI Assistance for Clinicians Identifying Causes of Chest Pain From ECG Images

12 novembre 2026 mis à jour par: Shenda Hong, Peking University Health Science Center

A Two-Arm Parallel-Group Randomized Trial of ZERO-Assisted and Unassisted Clinicians Identifying Causes of Chest Pain From Real-World ECG Images

This study will assess whether reports generated by ZERO, a mobile system for interpreting electrocardiogram (ECG) images, improve clinicians' ability to identify causes of chest pain compared with interpretation without AI assistance.

A total of 120 licensed cardiology clinicians will be randomly assigned in a 1:1 ratio to ZERO-assisted or unassisted interpretation. Each clinician will assess 30 ECG cases during a single session lasting up to 60 minutes. The cases will include five examples from each of six diagnostic categories: unstable angina, non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, aortic dissection, pulmonary embolism, and other diagnoses. No case or patient will be repeated within or across clinicians.

For each case, clinicians will first review the ECG and submit an initial diagnosis that cannot subsequently be changed. Clinicians in the ZERO-assisted group will then view a fixed report generated before clinician randomization. Clinicians in the unassisted group will review the ECG again without an AI report. All clinicians will then submit a final diagnosis.

Diagnostic performance will be assessed against clinical reference diagnoses established before the interpretation task and withheld from participating clinicians. The study will use ECG cases from completed clinical encounters and will not affect patient care. The hypothesis is that ZERO-assisted clinicians will achieve higher final diagnostic accuracy than unassisted clinicians.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

120

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 110 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Licensed cardiology clinicians who routinely participate in the diagnosis or management of chest pain or cardiovascular disease and interpret electrocardiograms (ECGs).
  • Able to read Chinese-language reports and use the study platform.
  • Willing to provide electronic informed consent and sign a confidentiality statement.
  • Willing to complete all 30 assigned ECG interpretation tasks within the specified study period.

Exclusion Criteria:

  • Access to the reference diagnoses of the study cases, or involvement in screening, selecting, or adjudicating these cases.
  • Prior knowledge of the answers to the study cases through participation in model development or previous experiments.
  • Duplicate enrollment.
  • Inability to complete training in the use of the study platform.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Diagnostique
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Aucune intervention: No AI Assistance

Clinicians will interpret 30 unique ECG cases, with five cases from each diagnostic category, during a single session lasting up to 60 minutes. For each case, clinicians will review the ECG image and submit an initial first-choice diagnosis, which will then be locked. They will subsequently review the same ECG image again without an AI report and submit a final first-choice diagnosis, which will also be locked.

Expérimental: ZERO Assistance

Clinicians will first review each assigned ECG image and submit and lock an initial first-choice diagnosis. They will then view the fixed ZERO-generated report and submit and lock a final first-choice diagnosis. The report will include risk alerts for STEMI, aortic dissection, and pulmonary embolism, ranked diagnostic candidates, supporting explanations and available sources, and suggestions for further evaluation. If the report is unavailable or invalid, the failure will be recorded and the clinician may still submit a final diagnosis. Each clinician will complete 30 unique cases, with five cases per diagnostic category.

ZERO is a mobile system that processes de-identified ECG images and generates structured diagnostic reports. It integrates image preprocessing, a dedicated prediction model, risk stratification, knowledge retrieval, and report generation using GLM-4.6. Reports will be generated and stored before clinician randomization using a prespecified, frozen model, prompts, and retrieval configuration. During the interpretation task, the corresponding report will be displayed only after the clinician has submitted and locked the initial diagnosis. No additional patient information or clinician responses will be supplied to the system, and reports will not be modified during the task. No online adaptation will occur during the study.

Autres noms:
  • ZERO

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Finalfirst-choice diagnostic accuracy
Délai: 60 Minutes

For each clinician, final first-choice diagnostic accuracy will be calculated as the number of cases in which the final first-choice diagnosis matches the prespecified clinical reference diagnosis, divided by 30 and multiplied by 100%. Each clinician will assess five cases from each of six diagnostic categories. The outcome will be summarized as the mean clinician-level accuracy in each randomized group. Only clinicians with both an initial and a final diagnosis recorded for all 30 cases will be included in the diagnostic outcome analysis. The primary comparison will be between the ZERO-assisted and unassisted groups.

60 Minutes

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Final Missed-Diagnosis Percentage for ST-Segment Elevation Myocardial Infarction
Délai: 60 Minutes

Among clinicians with complete initial and final diagnoses for all 30 cases, the percentage of cases with a reference diagnosis of ST-segment elevation myocardial infarction for which the final first-choice diagnosis is not ST-segment elevation myocardial infarction. Each clinician's percentage will be calculated as the number of such cases divided by five and multiplied by 100%. The outcome will be summarized as the mean clinician-level percentage in each randomized group. Lower values indicate fewer missed diagnoses in the ECG interpretation task.

60 Minutes
Final Missed-Diagnosis Percentage for Aortic Dissection
Délai: 60 Minutes

Among clinicians with complete initial and final diagnoses for all 30 cases, the percentage of cases with a reference diagnosis of aortic dissection for which the final first-choice diagnosis is not aortic dissection. Each clinician's percentage will be calculated as the number of such cases divided by five and multiplied by 100%. The outcome will be summarized as the mean clinician-level percentage in each randomized group. Lower values indicate fewer missed diagnoses in the ECG interpretation task.

60 Minutes
Final Missed-Diagnosis Percentage for Pulmonary Embolism
Délai: 60 Minutes

Among clinicians with complete initial and final diagnoses for all 30 cases, the percentage of cases with a reference diagnosis of pulmonary embolism for which the final first-choice diagnosis is not pulmonary embolism. Each clinician's percentage will be calculated as the number of such cases divided by five and multiplied by 100%. The outcome will be summarized as the mean clinician-level percentage in each randomized group. Lower values indicate fewer missed diagnoses in the ECG interpretation task.

60 Minutes
Proportion of Cases Revised From an Incorrect to a Correct Diagnosis
Délai: 60 Minutes

For each clinician, the proportion will be calculated as the number of cases in which the initial first-choice diagnosis does not match the reference diagnosis but the final first-choice diagnosis does match it, divided by 30 and multiplied by 100%. The outcome will be summarized as the mean clinician-level proportion in each randomized group. The analysis will include only clinicians with complete initial and final diagnoses for all 30 assigned cases. Higher values indicate that more cases were corrected during the second assessment.

60 Minutes
Proportion of Cases Revised From a Correct to an Incorrect Diagnosis
Délai: 60 Minutes

For each clinician, the proportion will be calculated as the number of cases in which the initial first-choice diagnosis matches the reference diagnosis but the final first-choice diagnosis does not match it, divided by 30 and multiplied by 100%. The outcome will be summarized as the mean clinician-level proportion in each randomized group. The analysis will include only clinicians with complete initial and final diagnoses for all 30 assigned cases. Lower values indicate that fewer initially correct diagnoses became incorrect during the second assessment.

60 Minutes

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

19 novembre 2026

Achèvement primaire (Estimé)

11 décembre 2026

Achèvement de l'étude (Estimé)

18 décembre 2026

Dates d'inscription aux études

Première soumission

12 novembre 2026

Première soumission répondant aux critères de contrôle qualité

12 novembre 2026

Première publication (Réel)

18 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

12 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner